The Board of Directors of Blue Cross Blue Shield of Massachusetts (BCBSMA) has chosen Executive Vice President Andrew Dreyfus as the company's new president and chief executive officer. Dreyfus succeeds Bill Van Faasen who has served in an unpaid interim role of president and CEO since March 16, 2010.
The Board of Directors of Blue Cross Blue Shield of Massachusetts (BCBSMA) has chosen Executive Vice President Andrew Dreyfus as the company's new president and chief executive officer. Dreyfus succeeds Bill Van Faasen who has served in an unpaid interim role of president and CEO since March 16, 2010. Van Faasen will remain involved with the company in a role still to be determined.
"Andrew is not only an experienced leader in the industry and a nationally known expert on critical issues such as health reform and changing the way we pay for care, but as importantly, he has a broad understanding and passionate commitment to continuing and strengthening the important leadership role BCBSMA has played in our community since the company's founding 73 years ago," said BCBSMA Board Chairman Paul Guzzi in a statement announcing the decision.
Over the past five years, Dreyfus has served as BCBSMA's executive vice president for Health Care Services. He also led the development and execution of the company's Alternative Quality Contract (AQC), a new payment model that aligns physician and hospital payments with the quality of care patients receive.
Dreyfus has been a part of BCBSMA's executive leadership team since 2001, when he was selected as the first president of the Blue Cross Blue Shield of Massachusetts Foundation. Prior to joining BCBSMA in 2001, Dreyfus was an executive vice president at the Massachusetts Hospital Association and held senior positions in the Massachusetts Executive Office of Human Services and the Executive Office of Consumer Affairs and Business Regulation.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Effective July 1, 2025, this agreement ensures that nearly 400,000 patients covered by IBX each year will keep receiving quality care from Penn Medicine providers. The partnership focuses on improving health outcomes, patient experiences, and controlling costs, aiming to set new standards for innovative care in healthcare, according to a release.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen